← FDA DRUG APPROVALS

FDA NDA · NDA018014

DOPAMINE HYDROCHLORIDE

Sponsor: INTL MEDICATION

APPLICATION
NDA018014
TYPE
NDA
ORIGINAL APPROVAL
1981-05-19
LATEST ACTION
1998-01-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOPAMINE HYDROCHLORIDEDiscontinued
DOPAMINE HYDROCHLORIDE 40MG/ML · INJECTABLE · INJECTION

Approval history

1998-01-14Manufacturing (CMC) · Supplement 22AP
1995-09-19Manufacturing (CMC) · Supplement 24AP
1994-06-17Manufacturing (CMC) · Supplement 23AP
1993-10-29Manufacturing (CMC) · Supplement 21AP
1992-12-17Manufacturing (CMC) · Supplement 20AP
1992-08-11Manufacturing (CMC) · Supplement 19AP
1991-10-23Labeling · Supplement 18AP
1991-06-12Labeling · Supplement 17AP
1991-02-21Manufacturing (CMC) · Supplement 12AP
1986-05-20Manufacturing (CMC) · Supplement 10AP
1981-05-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →